Derick Kimathi
Kilifi, Kenya
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
Journal: Lancet (London, England)
Published: June 14, 2025
Low-Dose Yellow Fever Vaccine in Adults in Africa.
Journal: The New England journal of medicine
Published: February 19, 2025
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country.
Journal: Human vaccines & immunotherapeutics
Published: December 26, 2024
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Journal: The Lancet. Infectious diseases
Published: November 07, 2022
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Journal: The Lancet. Infectious diseases
Published: November 07, 2022
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
Journal: Vaccines
Published: May 10, 2021
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Journal: Lancet (London, England)
Published: August 25, 2020
Factors influencing the implementation of cardiovascular risk scoring in primary care: a mixed-method systematic review.
Journal: Implementation science : IS
Published: February 11, 2020
Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda.
Journal: Wellcome open research
Published: November 14, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026